跳至主要内容
临床试验/ACTRN12618000888268
ACTRN12618000888268已完成未知

Feasibility of an early commencing hospital-based exercise program to prevent functional decline in people with haematological malignancy treated with allogeneic bone marrow transplant: the BOOST study

Royal Melbourne Hospital0 个研究点目标入组 42 人开始时间: 2018年5月28日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
42

研究概览

简要总结

/A as yet.

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • The safety of each participant to participate in exercise will be assessed daily on an individual basis. In order to participate in group exercise on any given day, participant's must fulfil the following safety criteria:
  • - Vital observations within normal limits as per hospital protocol
  • - Platelet count greater than or equal to 15 x 10^9/L (resistance exercise can commence when platelet count is 20 or greater)
  • - Haemoglobin count greater than 80 g/L
  • - If a participant is in contact isolation, they may participate in group exercise if they wear gloves; if a participant is in respiratory isolation, they may not participate in group exercise.
  • - Note, as the exercise group takes place on a pressurised ward there is no contraindication to group exercise with low neutrophil count.
  • - Note, all participants are advised to practice hand hygiene and clean equipment before/after use.

排除标准

  • Severe active psychiatric or cognitive disorder or unable to provide consent; presence of a musculoskeletal co-morbidity preventing exercise.

研究者

相似试验